Document is current
Any future updates will be listed below
-
Authors
Sinning, Christoph http://orcid.org/0000-0002-7331-8840
Makarova, Nataliya
Völzke, Henry
Schnabel, Renate B.
Ojeda, Francisco
Dörr, Marcus
Felix, Stephan B.
Koenig, Wolfgang
Peters, Annette
Rathmann, Wolfgang
Schöttker, Ben
Brenner, Hermann
Veronesi, Giovanni
Cesana, Giancarlo
Brambilla, Paolo
Palosaari, Tarja
Kuulasmaa, Kari
Njølstad, Inger
Mathiesen, Ellisiv Bøgeberg
Wilsgaard, Tom
Blankenberg, Stefan
Söderberg, Stefan
Ferrario, Marco M.
Thorand, Barbara http://orcid.org/0000-0002-8416-6440
-
Funding
Funding for this research was provided by:
eu projects morgam (BMH4-CT98-3183)
genomeutwin (QLG2-CT-2002-01254)
engage (HEALTH-F4-2007-201413)
chances (HEALTH-F3-2010-242244)
biomarcare (HEALTH-F2-2011-278913)
eucanshare (No. 825903)
affect-eu (No. 847770)
medical research council, london (No. 80983)
- License Information
-
More Information
Article History
Received: 2 August 2021
Accepted: 4 November 2021
First Online: 15 November 2021
Change Date: 18 May 2022
Change Type: Update
Change Details: The original publication was missing a funding note declaring funding enabled by Projekt DEAL.
Declarations
:
: The studies contributing data were conducted in accordance with the principles of the Declaration of Helsinki. Please also refer to the online Additional file InternalRef removed: Table S1.
: Not applicable.
: Dr. Sinning is deputy editor of the European Heart Journal—Case Reports and BioMed Central editorial board member for BMC Cardiovascular Disorders. Dr. Söderberg reports grants and other from Actelion Ltd, outside the submitted work. Dr. Schnabel reports personal fees from BMS/Pfizer, outside the submitted work. Dr. Makarova reports personal fees from Abbott Laboratories, outside the submitted work. Dr. Koenig reports personal fees from AstraZeneca, personal fees from Novartis, personal fees from Pfizer, personal fees from The Medicines Company, personal fees from GSK, personal fees from DalCor, personal fees from Sanofi, personal fees from Berlin-Chemie, personal fees from Kowa, personal fees from Amgen, grants and non-financial support from Roche Diagnostics, grants and non-financial support from Beckmann, grants and non-financial support from Singulex, grants and non-financial support from Abbott, all outside the submitted work. Dr. Blankenberg reports grants and personal fees from Abbott Diagnostics, grants and personal fees from Bayer, grants and personal fees from SIEMENS, grants from Singulex, grants and personal fees from Thermo Fisher, personal fees from Astra Zeneca, grants and personal fees from Bayer, personal fees from AMGEN, personal fees from Medtronic, personal fees from Pfizer, personal fees from Roche, personal fees from Siemens Diagnostics, personal fees from Novartis, personal fees from Abbott, all outside the submitted work. All other authors have nothing to disclose in relation to the current study.
